Formerly at Kos Pharmaceuticals
Parexel Names Rieder CIO
The CRO picks a technology strategist. more...
The CRO picks a technology strategist. more...
A 20-year-old Londoner will be unable to fulfill his dream of becoming a plumber after participating in a clinical trial under the auspices of a German sponsor, TeGenero. more...
In the latest announcement of a CRO pushing into new global markets, the technology-oriented i3 announced the purchase of a company in Latin America and a new office in India. more...
The Illinois company issued a news release that noted it has supported 300 trials since the company’s inception in 1995. more...
In November, the company named two new executives to shepherd its push into Japan: Tetsushi Inada and Kevin Keim. more...
Doubling its headquarters staff, Quintiles will add 1,000 jobs (average salary: $65,000) in the Raleigh area over a period of five years. more...
The new arrangement with the U.S. company is mostly related to clinical trial data services, and the news release quotes the Indiana executive who oversees such matters. more...
In addition to the award in London, Kendle scored a major coup recently. It hired Sylva Collins, the architect of clinical data management systems at Novartis. more...
In a 30-month international trial, the firm’s technology will be used to evaluate biomarkers in arthritis. more...
Independent research firm says sponsors of clinical trials will increasingly need services and technology from both firms. more...
UBC buys CRO with 85 employees specializing in biostatistics, medical writing. more...
Large pharma uses Pegus Research, DSG to collect data on the real-world transition from prescription to over-the-counter usage. more...
Company also has interactive products for evaluating athletes and workplace injuries. more...
The new lab is to be located in Leela Business Park in Mumbai, joining Quintiles’ core clinical research and electrocardiogram (ECG) businesses. more...
Shares in contract research organization Pharmaceutical Product Development (PPD) dropped 4 percent yesterday after the company said President Fred B. Davenport Jr. is leaving. Wall street analysts, however, are uniformly upbeat on the company’s prospects. more...
A patient infected with TB was inadvertently included in a Montreal study under the auspices of SFBC Anapharm. Canadian press reports say the patient infected 20 people, both staff and other trial participants. more...
Organizations
Conferences
Info & Opinion
© 2013 ClinPage. All Rights Reserved.